Human IgG antibody Laboratories manufactures the liasolin control sars cov reagents distributed by Genprice. The Liasolin Control Sars Cov reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Control. Other Liasolin products are available in stock. Specificity: Liasolin Category: Control Group: Sars Cov
Positive control tissue section for each antibody; Based on availability INQUIRE |
|||
| Control-Slides | Innovex | Set of 5 | EUR 211.2 |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) |
|||
| NATSARS(COV2)-NEG | Zeptometrix | 6 x 0.5 mL | EUR 172 |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 1.0 mL) |
|||
| NATSARS(COV2)-NEG1 | Zeptometrix | 6 x 1.0 mL | EUR 216 |
NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) |
|||
| NATCV9-6C | Zeptometrix | 6 x 0.5mL | EUR 194 |
NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
|||
| NATFRC-6C | Zeptometrix | 6 x 0.5mL | EUR 229 |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) |
|||
| NATSARS(COV2)-ERC | Zeptometrix | 6 x 0.5 mL | EUR 378 |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 1.0 mL) |
|||
| NATSARS(COV2)-ERC1 | Zeptometrix | 6 x 1.0 mL | EUR 516 |
SARS-CoV Nucleocapsid Recombinant Protein |
|||
| 11-173 | ProSci | 0.1 mg | EUR 752.1 |
|
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool. |
|||
SARS-CoV-2 Spike Peptide |
|||
| 9083P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (NT) SARS-CoV-2 Spike peptide |
|||
SARS-CoV-2 Spike Peptide |
|||
| 9087P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (CT) SARS-CoV-2 Spike RBD peptide |
|||
SARS-CoV-2 Spike Peptide |
|||
| 9091P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Spike peptide |
|||
SARS-CoV-2 Spike Peptide |
|||
| 9095P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Spike peptide |
|||
SARS-CoV-2 Nucleocapsid Peptide |
|||
| 9099P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Nucleocapsid peptide |
|||
SARS-CoV-2 Nucleocapsid Peptide |
|||
| 9103P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: (CT) SARS-CoV-2 Nucleocapsid peptide |
|||
Anti-SARS-CoV-2 Antibody |
|||
| A2061-50 | Biovision | 50 µg | EUR 576 |
SARS-CoV spike protein Antibody |
|||
| abx023139-100ug | Abbexa | 100 ug | EUR 1028.4 |
SARS-CoV spike protein Antibody |
|||
| abx023143-100ug | Abbexa | 100 ug | EUR 1028.4 |